SINGAPORE-- Fujifilm's Toyama Chemical is readying a study for a scientific journal stating that its Avigan (favipiravir) influenza drug has shown promise in treating ebolavirus so far in an early-phase clinical trial in the West African country of Guinea.
SINGAPORE-- Wockhardt's chairman told reporters the company's Illinois production plant, responsible for half its sales in the United States, has taken care of the issues that led the FDA to issue it a Form 483 citing compliance failures last year.
SINGAPORE-- Harbin Gloria Pharmaceuticals will pay RMB 2.39 billion to acquire an 85% stake in Shanxi Powerdone Pharmaceutics, one of two domestic deals in late January involving mainland firms reshuffling biotech assets and traditional Chinese medicines.
SINGAPORE-- Despite missing its target for bringing 15 to 20 drugs to the U.S. market last year, Lupin is optimistic enough about 2015 that it seeks possible acquisitions in Russia to expand its presence there.
The U.S. FDA is hiring new inspectors in India to tackle the high rate of marketing applications made by local firms, an agency official said.
SINGAPORE-- Sometimes it must seem to Pakistan's health authorities they can do nothing right in regulating the nation's pharmaceutical industry.
With recent news of clinical trials for its low-cost HPV vaccine, the Serum Institute has already made waves in the world of Big Pharma. The India-based vaccinemaker is now gearing up to challenge the world's leading vaccinemakers in another area: pertussis.
India's health ministry reportedly is drafting a requirement that pharmaceuticals carry barcodes at the primary level of packaging.
MicroConstants China has signed a licensing agreement to gain the global rights for the development of AA98 antibody drug candidates from the Institute of Biophysics of the Chinese Academy of Sciences in a unique deal between academia and local industry.
When the just-ended New York negotiations failed to resolve drug-patenting and other intellectual property issues, the focus shifted to a ministerial-level meeting of the Trans-Pacific Partnership expected to take place in March.